Survey the effect of Taurolock on central venous catheter infection in dialysis patients.
Phase 1
- Conditions
- End stage kidney disease.End stage kidney disease
- Registration Number
- IRCT2016020221066N2
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients undergoing chronic hemodialysis through Permi – Ket; written consent of the patient.
Exclusion criteria: IV Drug Abuse; Change the dialysis of Permi – Ket to the AVF; Having a history of surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infection. Timepoint: Baseline, Once every three months, end of the study. Method of measurement: In the laboratory by blood cultures.
- Secondary Outcome Measures
Name Time Method